Anita Moorjani — The Coma, the Chemotherapy, and the Recovery (2006)

Anita Moorjani was wheeled into Hong Kong Sanatorium & Hospital in early February 2006 weighing about 36 kilograms, her lungs filling with fluid, her skin broken by lesions, her organs failing. She had been diagnosed with Hodgkin lymphoma four years earlier, in February 2002, and had refused chemotherapy ever since — she had watched her closest friend and her brother-in-law die of cancer under full treatment, and wanted none of it. Within hours of admission she was in a coma. Her husband was told she was unlikely to survive 36 hours.

Two things were done immediately. Specialists tapped her chest and drained the fluid that was killing her. And chemotherapy — the treatment she had refused for the better part of four years — was started while she was comatose, with her family's consent.

She woke after about 30 hours. By her account, her organs began working again within a day, and the tumors that ran from her skull to her abdomen shrank by about 60 percent within four days; other accounts of the case say 70. Five weeks after admission she walked out of the hospital with scans showing no detectable cancer. Chemotherapy continued for months while every test stayed clear, and a lymph-node biopsy found no disease. Twenty years later she remains publicly cancer-free.

What she says happened during those 30 hours became a book. In the coma, she reports, she was aware of conversations taking place outside her room, met her father, who had died years before, and chose to come back. Dying to Be Me was published in March 2012 and reached the New York Times bestseller list within two weeks.

The Two Oncologists

The medical dispute sits in plain view, which is rare for this genre. T.K. Chan, the oncologist-hematologist who treated her, told the South China Morning Post in February 2007: 'Whether the spiritual experience helped, I'm not in a position to say... It was a remarkable recovery. But I feel it was the chemotherapy, definitely, and the emergency draining of the chest.' He added that Hodgkin's disease 'is quite curable' and 'can have a dramatic response to chemotherapy.'

Peter Ko, an oncologist who reviewed her medical records in November 2006, read the same file the other way: 'chemotherapy does work well with Hodgkin's, but I've never seen it work like this.' Ko's assessment is genuinely on the record, and it has circulated mainly through channels sympathetic to near-death-experience research — worth knowing when weighing it. No peer-reviewed case report of her recovery has ever been published, and the medical file is private.

The Case For and Against

This is a Mode A claim — one that would violate natural law if the recovery exceeded what medicine can do. The natural account is unusually strong. Hodgkin lymphoma answers chemotherapy faster and more completely than almost any other cancer; rapid tumor shrinkage after a first cycle is documented behavior. The drainage removed the thing about to kill her. And the timing settles nothing, because the experience and the treatment began in the same hours: a recovery that started when the chemotherapy started cannot be assigned to either by the clock. What the natural reading has to absorb is the starting point — a patient in multi-organ failure whose own doctors expected her to die with or without treatment — and one reviewing oncologist's statement that he had never seen chemotherapy do this.

Where This Lands

We put the probability that no natural account covers this at low, and the headline probability at 9 percent. The recovery is real, was fast, and is documented in outline by independent reporting and her treating physician's own interview. The speed and the interior detail flow through her own accounts, the figures vary between her own writings and secondhand retellings, and the one treatment known to do exactly this began the day she arrived. She has told the same account for twenty years. T.K. Chan's is on the record in the South China Morning Post, February 2007.